health research institute pwc

Search form

• Newsletters

• Reimbursement
• Revenue Cycle Management
• Strategic Planning
• Capital Finance
• Supply Chain
• Accounting & Financial Management
• Ambulatory Care
• Billing and Collections
• Business Intelligence
• Claims Processing
• Community Benefit
• Compliance & Legal
• Construction & Facilities Management
• Hospital/physician relations
• ICD-10 & Coding
• Meaningful Use
• Medical Devices
• Medicare & Medicaid
• Mergers & Acquisitions
• Patient Engagement
• Policy and Legislation
• Population Health
• Quality and Safety
• Risk Management

PwC's Health Research Institute Adds Regulatory Analysis Capability

PwC US today announced the expansion of its health industry research arm to include a new team focused on healthcare policy and regulatory issues. The team, which joins PwC's Health Research Institute (HRI), tracks and analyzes legislative and regulatory issues across the U.S. health landscape, delivering timely business insights to help executive decision makers navigate rapid change.

PwC's new HRI regulatory team includes: Bobby Clark, Matt DoBias and Caitlin Sweany, and is overseen by Benjamin Isgur, a director and former legislative director for the Texas House of Representatives. HRI is led by managing director Ceci Connolly, a veteran Washington journalist and author.

"The pace and plethora of rules that health organizations must comply with makes decision makers susceptible to information overload and knowledge deficiency," said Kelly Barnes, PwC's US Health Industries Leader. "We're pleased to welcome this talented new team to PwC's Health Research Institute as we aim to not only help clients stay abreast of crucial issues, but one step ahead. We're committed to providing clients with insightful knowledge in real time to navigate this dynamic, highly regulated industry and enable strategic decision making."

Based in Washington, DC, the regulatory team issues a weekly report and periodic in-depth examinations of major legislative and regulatory developments, providing analysis on the implications for organizations across the health spectrum, including insurers, providers, pharmaceutical and medical device companies, as well as employers and consumers. This regulatory team builds on the primary research and analytic capabilities of HRI:

Matt DoBias, an award-winning journalist, is focused on a range of regulatory and policy issues that affect hospitals and physicians. As a former policy reporter, DoBias produced high-impact coverage of the debate over the Affordable Care Act. He has held staff positions at Modern Healthcare, National Journal and Politico. He is a graduate of Virginia Commonwealth University in Richmond, Virginia. Bobby Clark was formerly director of federal affairs at Teva Pharmaceuticals and an advisor to Congressman Frank Pallone, Jr. and the House Committee on Energy and Commerce, Subcommittee on Health before joining PwC. Clark is focused on the analysis of legislative and regulatory initiatives affecting the life sciences sector. He holds a bachelor's degree from Rutgers University and a master's degree in public policy from Georgetown University, where he specialized in healthcare policy. Caitlin Sweany, a consultant with PwC's Health Industries practice, transfers to the regulatory team to cover issues facing the insurance industry and other healthcare purchasers, such as state governments. Before joining PwC, she was in the Health Care Bureau of the New York State Office of the Attorney General where she provided research support and analysis on healthcare matters. Sweany earned a master's degree from Columbia University's School of Public Health after graduating from Haverford College in Philadelphia with a bachelor's degree in biology.

PwC's Health Research Institute publishes in-depth, data-driven reports and briefs on current and emerging health industry trends. Recently published reports include: an analysis on the impact of the 2012 Presidential elections and the 113th U.S. Congress, an in-depth look at the demographic profile of the 30 million newly-insured population under the Affordable Care Act and new patients under the law's Medicaid expansion.

For more information, visit: www.pwc.com/us/hriregdesk .

About PwC's Health Research Institute (HRI) PwC's Health Research Institute provides new intelligence, perspectives and analysis on trends affecting all health-related industries. The Health Research Institute helps executive decision makers navigate change through primary research and collaborative exchange. HRI's views are shaped by a network of professionals with executive and day-to- day experience in the health industry. PwC's research is independent and not sponsored by businesses, government or other institutions.

About PwC's Health Industries Group PwC's Health Industries group ( www.pwc.com/us/healthindustries ) is a leading advisor to public and private organizations across the health industries, including healthcare providers, pharmaceuticals, health and life sciences, payers, employers, academic institutions and non-health organizations with significant presence in the health market. Follow PwC Health Industries at @PwCHealth.

About the PwC Network PwC firms help organizations and individuals create the value they're looking for. We're a network of firms in 158 countries with more than 180,000 people who are committed to delivering quality in assurance, tax and advisory services. Tell us what matters to you and find out more by visiting us at www.pwc.com .

Learn more about PwC by following us online: @PwC_LLP, YouTube, LinkedIn, Facebook and Google +.

PwC's Health Research Institute Adds Regulatory Analysis Capability

Bobby Clark, Matt DoBias, and Caitlin Sweany join PwC's Health Research Institute regulatory team

News provided by

Nov 27, 2012, 01:22 ET

Share this article

WASHINGTON , Nov. 27, 2012 /PRNewswire/ --  PwC US today announced the expansion of its health industry research arm to include a new team focused on healthcare policy and regulatory issues.  The team, which joins PwC's Health Research Institute (HRI), tracks and analyzes legislative and regulatory issues across the U.S. health landscape, delivering timely business insights to help executive decision makers navigate rapid change.

(Logo: http://photos.prnewswire.com/prnh/20100917/NY66894LOGO )

PwC's new HRI regulatory team includes: Bobby Clark , Matt DoBias and Caitlin Sweany , and is overseen by Benjamin Isgur , a director and former legislative director for the Texas House of Representatives.  HRI is led by managing director Ceci Connolly , a veteran Washington journalist and author.

"The pace and plethora of rules that health organizations must comply with makes decision makers susceptible to information overload and knowledge deficiency," said Kelly Barnes , PwC's US Health Industries Leader.  "We're pleased to welcome this talented new team to PwC's Health Research Institute as we aim to not only help clients stay abreast of crucial issues, but one step ahead.  We're committed to providing clients with insightful knowledge in real time to navigate this dynamic, highly regulated industry and enable strategic decision making."

Based in Washington, DC , the regulatory team issues a weekly report and periodic in-depth examinations of major legislative and regulatory developments, providing analysis on the implications for organizations across the health spectrum, including insurers, providers, pharmaceutical and medical device companies, as well as employers and consumers.  This regulatory team builds on the primary research and analytic capabilities of HRI:

• Matt DoBias , an award-winning journalist, is focused on a range of regulatory and policy issues that affect hospitals and physicians.  As a former policy reporter, DoBias produced high-impact coverage of the debate over the Affordable Care Act.  He has held staff positions at Modern Healthcare , National Journal and Politico .  He is a graduate of Virginia Commonwealth University in Richmond, Virginia .
• Bobby Clark was formerly director of federal affairs at Teva Pharmaceuticals and an advisor to Congressman Frank Pallone, Jr. and the House Committee on Energy and Commerce, Subcommittee on Health before joining PwC.  Clark is focused on the analysis of legislative and regulatory initiatives affecting the life sciences sector.  He holds a bachelor's degree from Rutgers University and a master's degree in public policy from Georgetown University , where he specialized in healthcare policy.
• Caitlin Sweany , a consultant with PwC's Health Industries practice, transfers to the regulatory team to cover issues facing the insurance industry and other healthcare purchasers, such as state governments. Before joining PwC, she was in the Health Care Bureau of the New York State Office of the Attorney General where she provided research support and analysis on healthcare matters.  Sweany earned a master's degree from Columbia University's School of Public Health after graduating from Haverford College in Philadelphia with a bachelor's degree in biology.

PwC's Health Research Institute publishes in-depth, data-driven reports and briefs on current and emerging health industry trends.  Recently published reports include: an analysis on the impact of the 2012 Presidential elections and the 113th U.S. Congress, an in-depth look at the demographic profile of the 30 million newly-insured population under the Affordable Care Act and new patients under the law's Medicaid expansion.

For more information, visit: www.pwc.com/us/hriregdesk .  

About PwC's Health Research Institute (HRI) PwC's Health Research Institute provides new intelligence, perspectives and analysis on trends affecting all health-related industries. The Health Research Institute helps executive decision makers navigate change through primary research and collaborative exchange. HRI's views are shaped by a network of professionals with executive and day-to- day experience in the health industry. PwC's research is independent and not sponsored by businesses, government or other institutions.

About PwC's Health Industries Group PwC's Health Industries group ( www.pwc.com/us/healthindustries ) is a leading advisor to public and private organizations across the health industries, including healthcare providers, pharmaceuticals, health and life sciences, payers, employers, academic institutions and non-health organizations with significant presence in the health market. Follow PwC Health Industries at @PwCHealth .

About the PwC Network PwC firms help organizations and individuals create the value they're looking for. We're a network of firms in 158 countries with more than 180,000 people who are committed to delivering quality in assurance, tax and advisory services. Tell us what matters to you and find out more by visiting us at www.pwc.com .

Learn more about PwC by following us online: @PwC_LLP , YouTube , LinkedIn , Facebook and Google + .

© 2012 PricewaterhouseCoopers LLP, a Delaware limited liability partnership. All rights reserved. PwC refers to the US member firm, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.

SOURCE PwC US

Modal title

• Free In-Person Regional Events Focused on Oncology and Population Health

• Conferences

PwC Health Research Institute Unveils Impending Top Health Industry Issues of 2020

In PwC Health Research Institute’s report, “Top health industry issues of 2020: Will digital start to show an ROI?” researchers highlighted the forces that will most powerfully affect the health industry in 2020, with a chief focus on the concern emerging from revisions to overseas tax provisions.

In PwC Health Research Institute’s report , “Top health industry issues of 2020: Will digital start to show an ROI?” researchers highlighted the forces that will most powerfully affect the health industry in 2020, with a chief focus on the concern emerging from revisions to overseas tax provisions.

The report distinguishes a variety of issues that will impact current standards employed by US health industries in the upcoming year. Researchers focused on 7 headline items:

• A looming tsunami of high prices
• Regulation trumps policy
• Consumers inch closer to do-it-yourself healthcare
• US health organizations are seeking opportunities overseas and through innovation—beware of the tax risks
• A whole new you: Deals as makeovers
• Equity and inclusion, not just diversity, as a business imperative

One issue in particular, the growing innovation of US-based healthcare organizations overseas, has become concerning amid changing tax provisions, primarily among based-for-profit provider companies, tax-exempt provider organizations, payers, and life sciences companies. According to the report, 85% of these top US-based companies are operating overseas. As 90% of this group is also seeking income in innovation, whether it is venture capital funds, operating accelerators, or partnerships, potential tax provisions curbing their profits threatens to not only harm their respective operations but also those benefitting from their services in places worldwide.

To assist members’ tax profits where business activity takes place, the Group of 20 and the Organization for Economic Cooperation and Development (OECD) have taken initiative by publishing guidance, called BEPS 1.0, which educates member nations on base erosion and profit shifting. However, BEPS guidance is being adopted unevenly across nations, even though it addresses issues including treaty abuse, transfer pricing, and mobile workforces.

Adherence to these recommendations could prove vital as researchers noted that international taxation could be materializing. This past October, the Secretariat of the OECD published a proposal, called the Pillar 1 Unified Approach, that would allocate taxing rights to nations where digital consumers are located rather focusing on the location of the business. The Secretariat of the OECD additionally requested comments last month on its Global Anti-Base Erosion (GloBE) proposal, which would integrate common global minimum tax rules for nations part of the OECD framework, a move that could increase tax and compliance obligations for enterprises across industries.

These potential changes would affect the current state of large international businesses, particularly US-based companies with large ties overseas. Some examples provided by researchers are Centene Corporation, who operates in 32 states and 4 international markets, and Seattle-based Providence Health & Services, one of the largest tax-exempt providers in the United States. Providence operates 51 hospitals and more than 800 clinics in 7 states and has partnerships in Guatemala and Mexico.

The change in tax provisions will alter how organizations approach a myriad of functions, prompting a change in the international health industry landscape. “These issues mean extra planning by tax departments, human resources and C-suite executives. They could mean investments in expertise and technology to monitor and document the flow of workers traveling abroad, heightened awareness of changes around transfer pricing, and planning for deals that don’t result in adverse tax scenarios,” said the study authors.

Biosimilars and Employers: Strategies for Success

How Can Employers Leverage the DPP to Improve Diabetes Rates?

Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More

Key Issues Influencing 2022 Employer Health Care Strategy and Plan Design

Conference Coverage: April 2024

Reducing Low-Value Care Is Hard, but What About Just Not Paying for It?

2 Commerce Drive Suite 100 Cranbury, NJ 08512

© 2024 MJH Life Sciences ® and AJMC® . All rights reserved.

• Fierce Pharma
• Fierce Biotech
• Fierce Healthcare
• Fierce Life Sciences Events
• AI and Machine Learning
• Digital Health
• Special Reports
• Special Report
• Awards Gala
• Fierce Events
• Industry Events
• Whitepapers

Payers should expect a 7% increase in healthcare costs next year: PwC

Healthcare costs will balloon 7% next year, as payers hammer out new contracts with providers, the labor shortage stretches on and drug prices continue to increase, according to a new report by PwC.

This represents a jump from PwC cost increase estimates in 2022 (5.5%) and 2023 (6%)

Researchers with PwC’s Health Research Institute spoke to insurance actuaries who work with health plans that cover over 100 million enrollees in employer-sponsored health plans and about 10 million individuals in plans on the Affordable Care Act marketplace.

However, the estimate is not set in stone, as the report said PwC adjusted its medical cost projection for the group market from 6.5% to 5.5% for 2022 due to fewer individuals receiving inpatient hospital care, as they opted instead to get care from outpatient sites.

“The higher medical cost trend in 2024 reflects health plans’ modeling for inflationary unit cost impacts from their contracted healthcare providers, as well as persistent double-digit pharmacy trends driven by specialty drugs and the increasing use of the GLP-1 agonists for Type 2 diabetes or weight loss,” the report said.

Health plans expect hospitals and physicians to seek not only rate increases but also shorter gaps between new contracts. Physician burnout and greater demand for surgeries and procedures post-COVID will also add to inflationary pressures, according to the report.

“Many health plan actuaries said they are facing increasing inflationary pressure on unit cost in 2023 and 2024,” the PwC report said. “Their ability to manage price increases during contract renewals will be a key factor in determining how the impact of inflation will materialize in the coming years.”

Employment in healthcare began to start recovering from the systemic shock rendered by COVID-19 in 2022, but there’s still a shortage, especially in nursing and workers in long-term care facilities and insurers can’t envision any short-term fix for this problem.

“Assuming the persistence of such shortages in 2024, hospitals will continue to be financially challenged and forced to seek higher reimbursement from payers,” the PwC report said. “On the other hand, if healthcare employment levels return to a stable level in 2024, pent-up demand for care is likely to drive utilization up. In both cases, health plans can expect to face inflationary pressure in 2024.”

Though health plans will continue to face a rising median price for new drugs, as well as price hikes for existing drugs, there are some deflationary indicators as well. For instance, biosimilars cost about 50% less than their reference drugs.

“The launch of adalimumab biosimilars to Humira in 2023 is a new milestone in the market that is already driving significant savings,” the PwC report said

Health plans see other factors at play for the rest of this year and next year, and while those might spur hope for controlling costs, that hope will arrive sometime in the future, having negligible effects on what’s going on now.

For instance, insurers will keep investing in total cost of care initiatives such as value-based care.

“National health plans generally demonstrated better cost management and subsequently achieved lower cost trends,” the PwC report said. “As these national plans continue to grow, they will have a deflator effect overall on medical cost trends.”

In addition, while health plans expect the demand and utilization of behavioral healthcare to rise, that won’t be a major inflationary problem, as behavioral healthcare is less expensive than other medical costs, according to the report.

The New Equation

Executive leadership hub - What’s important to the C-suite?

Tech Effect

Shared success benefits

Loading Results

No Match Found

Join the conversation at HR Tech 2024

Elevate your workforce.

Be a part of a discussion series about the pivotal role of HR leaders in transforming organizations through AI. Dive into how GenAI can be utilized to upskill your workforce and how data and people analytics can become your secret weapon in making strategic, informed decisions that elevate your workforce. Explore the potential of skills-based organizations and the importance of strategic workforce planning. Discover how to leverage cutting-edge technology and data to optimize talent deployment, transforming your HR function into a strategic powerhouse. Be part of the future of HR, where siloed data is a thing of the past and insightful enterprise perspectives are the new norm.

Our sessions

Enabling the skill shift: the need for talent transformation, what the workforce wants: the forces shaping the future of the workplace, the strategic advantage of people analytics: unleashing your full potential, strategic hr in the age of genai: realizing value and securing c-suite buy-in, workforce radar insights: shaping the future of work, elevating workforce efficiency: a case study on streamlined workforce transformation, enabling workforce transformation with genai: productivity, role redesign, and learning.

Wednesday, 9/25, 9:45 – 10:30 AM

In this dynamic discussion, we will explore the critical need for organizations to adapt to rapid technological advancements, particularly in the era of GenAI. We’ll delve into how disruptive technologies have historically transformed productivity and why the current technological revolution demands an even swifter response. By understanding the strategic importance of upskilling and reskilling, attendees will gain valuable insights into creating a resilient workforce ready to harness the full potential of emerging technologies.

We will discuss practical strategies for developing enterprise-wide upskilling programs, creating tailored learning pathways, and fostering a culture of continuous learning. This engaging session will equip HR leaders with the knowledge and tools needed to champion tech-enabled processes, ensuring their workforce remains agile and competitive in an ever-evolving digital landscape.

Speaker(s): Anthony Abbatiello, Workforce Transformation Leader, Partner, PwC US Jason Cerrato, VP of Talent-centered Transformation

Wednesday, 12:00 – 12:45 PM

This session will explore the key drivers behind workforce trends and what employees are looking for in their careers today. From learning new skills to the financial stresses affecting over half of the workforce, we will discuss how factors are reshaping employee expectations and behaviors. Discover why a significant portion of workers are considering changing employers for better opportunities to learn and grow, and what this means for organizations aiming to retain top talent.

We will also examine the role of technology, particularly AI, in creating new opportunities for skill development and how senior leaders can lead by example. Additionally, the session will address the critical elements of a modern workplace that fosters engagement, inclusivity, and well-being. Learn how to design meaningful and personal experiences that meet the needs of both the organization and its employees, and understand the importance of balancing work purpose with development opportunities.

Speaker(s): Adam Gerstein, Principal, Workforce Transformation, PwC US

Wednesday, 9/25, 2:45 – 3:30 PM

Part 1: The Core of People Analytics

Leveraging data is crucial for HR leaders. This session explores how advanced people analytics can elevate HR practices by offering insights for strategic decision-making. We’ll discuss the integration of GenAI and analytics to improve recruitment, onboarding, performance management, and employee engagement. Attendees will gain insights into real-world applications and learn about data-driven approaches for identifying skill gaps, optimizing workforce planning, and creating personalized employee experiences.

Part 2: HR Benchmarking for Strategic Action

Learn how HR benchmarks can guide executive-level decisions by comparing your turnover, talent acquisition, productivity and demographics to others in your industry. We’ll share national averages of 30 common HR metrics and demonstrate how benchmarks help you understand macroeconomic trends, set realistic goals, and drive continuous improvement.

Speaker(s): Guru Kashyap, Managing Director, Workforce Transformation, PwC US Mark Luetzelschwab, Director, Workforce Transformation, PwC US

Wednesday, 9/25, 5:00 – 5:45PM

In today’s challenging economic environment, HR leaders must achieve more with fewer resources. This session highlights how data and AI-driven tools can optimize HR strategies, streamline operations, and improve PandL outcomes. Learn to leverage GenAI and analytics to influence C-suite decisions, showcasing HR's strategic value and securing greater investment in HR technologies. 

Key learnings: 

• Data-driven HR strategies: Align better with business goals, drive PandL impact, and implement AI-powered automation
• Unlocking HRIS insights: Leverage GenAI to transform processes and uncover strategic opportunities
• GenAI-enhanced decision-making: Deliver comprehensive insights, benchmark against industry standards, and drive better PandL outcomes 
• GenAI in talent management: Improve skills identification, enhance candidate matching, reduce time-to-hire, and boost recruitment efficiency with GenAI
• C-suite engagement: Craft compelling, data-backed cases to secure increased HR investment

Speaker(s): Guru Kashyap, Managing Director, Workforce Transformation, PwC US Diane Youden, Principal, Workforce Transformation, PwC US

Thursday, 9/26, 9:30 – 10:15 AM

Join us for an exclusive session where we discuss the latest workforce trends, drawing on extensive interactions with clients, in-depth surveys, interviews with executives, and analysis across global organizations. This session will provide a deep dive into the dynamic and interconnected forces reshaping the workforce.

We will discuss how companies can leverage these insights to enhance employee engagement, drive performance, and navigate the complexities of the modern workplace. By exploring themes such as financial well-being, rewards and benefits, and workforce strategy, this session aims to equip HR and business leaders with the knowledge needed to make informed decisions and create a resilient, future-ready workforce.

Speaker(s): Anthony Abbatiello, Workforce Transformation Leader, Partner, PwC US

Thursday, 12:00 – 12:45 PM

In this session, we will explore the transformative power of streamlining workforce processes through the integration of advanced technologies and data-driven strategies. Attendees will learn how leveraging AI and automation can significantly enhance workforce management by reducing administrative burdens and enabling more informed decision-making. We'll discuss how to identify and address inefficiencies within an organization, ensuring that both business goals and employee needs are met effectively.

The session will also cover the impact of these technologies on employee engagement and satisfaction. By tailoring rewards and benefits packages based on data insights, organizations can foster a culture of continuous improvement and higher productivity. Real-world examples from various industries will illustrate the tangible benefits of these approaches, providing attendees with actionable insights to drive their own workforce transformations.

Speaker(s): Kris Khanna, Principal, Tech and Transformation, PwC US

Thursday, 9/26, 3:00 – 3:45PM

Join us for an enlightening session that delves into the revolutionary impact of GenAI on the workforce and HR’s new role in enabling it. We’ll explore how GenAI is reshaping the way we work, enhancing productivity, and redefining roles across various industries. This session will provide insights into the skills required to thrive in this rapidly changing landscape, emphasizing the critical role of HR in driving this transformation.

Experience the transformative power of GenAI as it automates tedious tasks and liberates your workforce to focus on more creative and strategic endeavors. From accelerating fraud detection to optimizing maintenance planning, GenAI is revolutionizing business operations by leveraging data analysis and predictive algorithms. Stay ahead of the curve by exploring innovative strategies to adapt, redesign roles, and embrace learning and upskilling. Prepare your team for this transformative technology and confidently navigate the future of work.

Speaker(s): Guru Kashyap, Managing Director, Workforce Transformation, PwC US

HR Tech from PwC

{{filtercontent.facetedtitle}}.

{{item.publishDate}}

{{item.title}}

{{item.text}}

Meet our speakers

Anthony leads PwC’s human capital consulting business, and is relentlessly passionate about executive leadership, workforce experience and driving bottom line results through human capital (and red wine).

Under Anthony’s leadership, PwC strives to be the industry leading advisor preparing clients for the workforce of the future. To do that, we solve client issues around HR and workforce strategy, behavioral change, and rewards and well-being. This includes employee experience, transformational leadership, talent architecture and next-gen change management. As a strategist and thought leader, Anthony has led extensive research on the global trends shaping today's workforce and have been named an HR Trendsetter for SHRM and Top 25 Consultant by The Consulting Report.

Anthony’s passion also comes through in social media - check out his LinkedIn blog at https://www.linkedin.com/in/apabbatiello/recent-activity/shares/ or follow on twitter @apabbatielloPWC

Anthony Abbatiello

Workforce Transformation Leader, Partner, PwC US

Adam Gerstein is a senior leader known for his human approach to successful transformation. As a principal on PwC’s workforce transformation team, he partners with leaders during watershed moments to drive growth and performance, evolve culture and employee experience, and strengthen trust among companies and their stakeholders.

Prior to joining PwC, Adam created and led the business transformation team at Edelman. He advised C-suite and senior executives on authentically leading transformational change. He collaborated on dozens of transactions, turnarounds, and business repositioning efforts for many of the world’s most recognized companies. Adam served in a similar capacity at Capgemini Consulting, where he was the leader of the people and performance practice in North America.

Adam began his private sector career at Citigroup, where he helped form the Corporate Affairs function following the merger of Travelers and Citicorp. Adam was a core member of the global team that oversaw corporate reputation; executive positioning; and internal and HR communications for 300,000 employees in more than 100 countries.

Adam got his start in local government where he was the speechwriter for New York City Council Speaker Peter F. Vallone, Sr.

Adam Gerstein

Principal, Workforce Transformation, PwC US

Guru is a Managing Director in PwC's Consulting Solutions segment and leads the practice area - Workforce Analytics and Products. He has rich experience in people analytics and is passionate about building high growth businesses-powered by innovation in data, AI, and cloud tech. Most recently, Guru was at Mercer as Chief Data and Analytics/Digital Officer and drove commercial data monetization priorities in their human capital business. Six months before the advent of ChatGPT, he spearheaded the delivery and launch of a Gen AI-infused product. Prior to that, over a 25-year career, he was a Chief Product Officer in Deloitte Digital and at a PE-backed/Softbank company and held several leadership roles in product and technology in the wireless industry.

Guru Kashyap

Managing Director, Workforce Transformation, PwC US

Kris Khanna is the driving force behind the SuccessFactors practice at PwC. With extensive experience in global HR and Payroll Transformations powered by SAP/SuccessFactors, Kris is dedicated to helping clients achieve success.

As a trusted advisor, Kris collaborates with complex, global clients, focusing on companies with intricate employee bases. His expertise lies in transforming Human Resource and workforce strategies, enhancing HR service delivery, and optimizing organizational structures with a business-driven approach. By leveraging strategic planning, organization design, process transformation, technology deployment, and governance, Kris works closely with large enterprises to generate tangible business value through effective human capital management.

Recognizing the value of collaboration, Kris emphasizes the strength of the partnership between PwC and SAP. Together, they offer a value equation that accelerates company-wide transformations, enabling organizations to thrive in the next generation. Leveraging PwC's profound sector expertise and business-led perspective, combined with SAP's cutting-edge software, they create systems of innovation that sustain continuous growth.

Kris Khanna

Principal, Tech and Transformation, PwC US

Dr. Mark Luetzelschwab leads the PwC Saratoga benchmarking team which provides hundreds of workforce benchmarks in over 20 major industries. In his 30+ years leading initiatives around skills and skill development, Mark has helped launch seven successful startups, led a division of a major non-profit, and created innovative new models for Amazon and PwC. His current focus is making sure everyone has access to the right data to make good decisions about their workforce.

Mark Luetzelschwab

Director, Workforce Transformation, PwC US

Diane is a HR Transformation partner, helping organizations modernize their HR function to support changing business and workforce needs and expectations. With tenacious curiosity, Diane welcomes the opportunity to explore the art of the possible with organizations to shape HR’s contributions to culture, careers, collaboration, and community. She is passionate about helping organizations rethink and reimage HR’s role through new services and modern technologies, inspiring new ways to engage and deliver services to leaders, managers, and employees.

With over 30 years of consulting, Diane has been a speaker at numerous conferences and internal corporate leadership events. Prior to her current role, Diane was the PwC Global Workday Leader, growing the business organically from inception and driving PwC’s Global professional services business in delivering Workday services. She was also the Diversity and Inclusion Leader for our Industrial Products and Services market segment.

A math and computer sciences graduate of the University of Texas - Arlington, Diane is a past board member of the YWCA, Dallas helping low-income women achieve stability and higher levels of self-sufficiency. She is also a volleyball and tennis mother, supporting her family’s multiple interests. Diane married a Texas native and now lives in Dallas with her husband, Robert, and son.

Diane Youden

Jason Cerrato is the Vice President of Talent-centered Transformation for Eightfold, focused on the capabilities of our comprehensive Talent Intelligence Platform and the future of work. Prior to Eightfold, he was with Gartner as a Senior Research Director, focusing on HR technology and transformation.

With extensive experience in talent acquisition, Jason spent more than a decade with United Technologies Corporation (now RTX), where he was the Senior Director of Talent Acquisition, serving as the workstream owner for recruiting and onboarding for an enterprise-wide global HR transformation initiative. Jason has a master’s degree in human resource development and received the Global Fellow in Talent Management certification from the Talent Management Institute and the Wharton School of Business.

Jason has been recognized by HR Executive as a Top 100 HR Tech influencer and also co-hosts The New Talent Code podcast, which provides insights and open discussion with industry leaders on all things talent and HR tech.

Jason Cerrato

VP of Talent-centered Transformation

Principal, Workforce Transformation, New York, PwC US

Thank you for your interest in PwC

We have received your information. Should you need to refer back to this submission in the future, please use reference number "refID" .

Required fields are marked with an asterisk( * )

Please correct the errors and send your information again.

By submitting your email address, you acknowledge that you have read the Privacy Statement and that you consent to our processing data in accordance with the Privacy Statement (including international transfers). If you change your mind at any time about wishing to receive the information from us, you can send us an email message using the Contact Us page.

© 2017 - 2024 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

• Data Privacy Framework
• Cookie info
• Terms and conditions
• Site provider
• Your Privacy Choices